CAMPFIRE: A Study of Abemaciclib (LY2835219) in Participants With Ewing's Sarcoma (clinicaltrials.gov) - Oct 22, 2026 - P2 | N=46 | Active, not recruiting | Sponsor: Eli Lilly and Company | Trial completion date: Dec 2026 ➔ Dec 2027
Trial completion date • Ewing Sarcoma • Oncology • Sarcoma • Solid Tumor
|